Back to Main Menu
linkedin chat-social x-social

What is the vision of the Biometrics BU in 2022?

With the backing of exciting new investors, ClinChoice is charting a new course that combines our expertise and ambition to aid the continuous development and monitoring of new drugs, devices, and vaccines. Listen to Mahesh Mudnur – President, Asia-Pacific, and Sridhar Punniamurthi – Director, Statistical Programming, as they share their vision for the Biometrics group in 2022.

  • This case study shows a real-world example of ClinChoice implementing FSP...


  • ClinChoice Opens Canadian Development Center - Expanding its North American...

    View Post

  • This review explores questions and considerations around custom-made, adaptable...